---
title: Ace Therapeutics vs VIRSCIO
slug_a: ace-therapeutics
slug_b: virscio
site: cro
review_signal_gate: closed
canonical_path: /compare/ace-therapeutics/virscio
---

# Ace Therapeutics vs VIRSCIO

Side-by-side profile data from each company listing on this directory.

## Ace Therapeutics

- Profile: [/companies/ace-therapeutics](/companies/ace-therapeutics)

Ace Therapeutics — Preclinical CRO providing integrated research services including efficacy testing, disease model development, PK/PD, toxicology, biomarker research, and safety assessment across respiratory, ophthalmology, cardiovascular, and neurology therapeutic areas.

Services: 0. Modalities: 0. Indications: 5. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in indications (5).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Indications

- Neurology
- Psychiatry
- Cardiovascular
- Respiratory
- Ophthalmology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.

## VIRSCIO

- Profile: [/companies/virscio](/companies/virscio)

VIRSCIO — Virscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.

Services: 8. Modalities: 3. Indications: 4. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- Specialized & Large-Animal Models
- Clinical Imaging Core Lab
- Regulatory Affairs
- Translational Research
- Pathology & Histology Services

### Modalities

- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Indications

- Neurology
- Metabolic
- Cardiovascular
- Ophthalmology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.